Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020.

Gender Post-COVID-19, Long-COVID, Long-Haulers SARS-CoV-2 Sex Women

Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Jan 2024
Historique:
medline: 12 1 2024
pubmed: 12 1 2024
entrez: 12 1 2024
Statut: ppublish

Résumé

BackgroundWomen are overrepresented among individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Biological (sex) as well as sociocultural (gender) differences between women and men might account for this imbalance, yet their impact on PASC is unknown.AimWe assessed the impact of sex and gender on PASC in a Swiss population.MethodOur multicentre prospective cohort study included 2,856 (46% women, mean age 44.2 ± 16.8 years) outpatients and hospitalised patients with PCR-confirmed SARS-CoV-2 infection.ResultsAmong those who remained outpatients during their first infection, women reported persisting symptoms more often than men (40.5% vs 25.5% of men; p < 0.001). This sex difference was absent in hospitalised patients. In a crude analysis, both female biological sex (RR = 1.59; 95% CI: 1.41-1.79; p < 0.001) and a score summarising gendered sociocultural variables (RR = 1.05; 95% CI: 1.03-1.07; p < 0.001) were significantly associated with PASC. Following multivariable adjustment, biological female sex (RR = 0.96; 95% CI: 0.74-1.25; p = 0.763) was outperformed by feminine gender-related factors such as a higher stress level (RR = 1.04; 95% CI: 1.01-1.06; p = 0.003), lower education (RR = 1.16; 95% CI: 1.03-1.30; p = 0.011), being female and living alone (RR = 1.91; 95% CI: 1.29-2.83; p = 0.001) or being male and earning the highest income in the household (RR = 0.76; 95% CI: 0.60-0.97; p = 0.030).ConclusionSpecific sociocultural parameters that differ in prevalence between women and men, or imply a unique risk for women, are predictors of PASC and may explain, at least in part, the higher incidence of PASC in women. Once patients are hospitalised during acute infection, sex differences in PASC are no longer evident.

Identifiants

pubmed: 38214079
doi: 10.2807/1560-7917.ES.2024.29.2.2300200
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Caroline E Gebhard (CE)

These authors contributed equally.
Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.

Claudia Sütsch (C)

These authors contributed equally.
Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Pimrapat Gebert (P)

Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Bianca Gysi (B)

Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.

Susan Bengs (S)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Atanas Todorov (A)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Manja Deforth (M)

Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Philipp K Buehler (PK)

Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Alexander Meisel (A)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Reto A Schuepbach (RA)

Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Annelies S Zinkernagel (AS)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Silvio D Brugger (SD)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Claudio Acevedo (C)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Dimitri Patriki (D)

Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.

Benedikt Wiggli (B)

Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland.

Jürg H Beer (JH)

Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland.
Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.

Andrée Friedl (A)

Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland.

Raphael Twerenbold (R)

Department of Cardiology and University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, Hamburg, Germany.
Department of Cardiology, University Hospital Basel, Basel, Switzerland.

Gabriela M Kuster (GM)

Department of Biomedicine, University of Basel, Basel, Switzerland.
Department of Cardiology, University Hospital Basel, Basel, Switzerland.

Hans Pargger (H)

Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.

Sarah Tschudin-Sutter (S)

Division of Infectious Diseases and Hospital Epidemiology, University of Basel, Basel, Switzerland.

Joerg C Schefold (JC)

Department of Intensive Care Medicine, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.

Thibaud Spinetti (T)

Department of Intensive Care Medicine, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.

Chiara Henze (C)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Mina Pasqualini (M)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Dominik F Sager (DF)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Lilian Mayrhofer (L)

Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.

Mirjam Grieder (M)

Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.

Janna Tontsch (J)

Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.

Fabian C Franzeck (FC)

Department of Informatics, University Hospital Basel, Basel, Switzerland.

Pedro D Wendel Garcia (PD)

Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Daniel A Hofmaenner (DA)

Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Thomas Scheier (T)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Jan Bartussek (J)

Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Ahmed Haider (A)

Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, and Department of Radiology, Harvard Medical School, Boston, Massachusetts, United States.
Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Muriel Grämer (M)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Nidaa Mikail (N)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Alexia Rossi (A)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Núria Zellweger (N)

Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.

Petra Opić (P)

Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.

Angela Portmann (A)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Roland von Känel (R)

Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Aju P Pazhenkottil (AP)

Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Michael Messerli (M)

Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Ronny R Buechel (RR)

Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Philipp A Kaufmann (PA)

Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Valerie Treyer (V)

Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Martin Siegemund (M)

Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.

Ulrike Held (U)

Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Vera Regitz-Zagrosek (V)

Institute of Gender in Medicine (GiM), Charité - Universitätsmedizin Berlin, Berlin, Germany.

Catherine Gebhard (C)

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Classifications MeSH